SUDAGRIP G Antigripal Injectable Solution – 1 Ampoule
$26.99
Experience effective relief with SUDAGRIP G Antigripal! This injectable solution contains Clorfeniramina Maleato and Fenilefrina to help combat severe cold symptoms, including fever and nasal congestion. Designed for easy injection, it’s perfect for those seeking continuity in their treatment. We ship to all 50 US states and Puerto Rico, and orders over $200 USD qualify for free shipping!
Order now and take the first step towards comfort!
Get your SUDAGRIP G Antigripal today!
Description
Active Ingredients: Each ampoule of SUDAGRIP G contains 8 mg of Clorfeniramina Maleato and 3 mg of Clorhidrato de Fenilefrina.
Dosage: Administer one 5 mL ampoule intramuscularly every 24 hours, as directed by your physician, for a duration not exceeding 3 to 5 days.
This injectable solution is designed to address severe cold symptoms and is effective in providing relief from discomfort associated with upper respiratory viral infections.
Precautions: Always consult your healthcare professional before starting any new medication. Follow the prescribed dosage and do not exceed the recommended duration of use.
Composition
Image and presentation note
Product image is for illustrative purposes. Packaging, presentation, or formula may vary without prior notice due to updates made by the manufacturer, laboratory, or product owner.
Medical Note
This injectable solution contains Clorfeniramina Maleato and Clorhidrato de Fenilefrina, which are antihistamines and decongestants. Always consult a healthcare professional before use.
Testimonial
“Laura, 29, from Chicago, mentioned how easy it was to navigate the website and ask questions through chat. She felt supported throughout her order process.”
¡Transforma tu bienestar hoy!
Descubre los mejores productos para tu salud y bienestar. Con un solo clic, recibe lo que necesitas directamente en tu puerta. ¡Hacemos envíos a Estados Unidos y Puerto Rico!
¡No esperes más! Compra ahora y mejora tu calidad de vida.
Reviews
There are no reviews yet.